| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |